Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Radezolid vs Linezolid in uSSSI
NCT00646958Phase 2Completed
- Sponsor
- Melinta Therapeutics
- Start
- Dec 2007
- Primary completion
- Apr 2008
- Modality
- RNA-Targeting Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of radezolid in Skin and Skin Structure Infection (SSSI), sponsored by Melinta Therapeutics. Started Dec 2007; status: completed.
02
Drugs
radezolid
03
Conditions
Skin and Skin Structure Infection (SSSI)
Beyond the preview
Go deeper on NCT00646958.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00646958.